Expertise in
9
conditions
Expertise in
9
conditions
2516 Stockton Blvd, Ste 384, 
Sacramento, CA 

Overview

Marcio Malogolowkin is a Pediatrics provider in Sacramento, California. Dr. Malogolowkin has been practicing medicine for over 44 years is highly rated in 9 conditions, according to our data. His top areas of expertise are Hepatoblastoma, Germ Cell Tumor, Adult Soft Tissue Sarcoma, Bone Marrow Aspiration, and Hepatectomy.

His clinical research consists of co-authoring 86 peer reviewed articles and participating in 47 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Federal University Of Rio Grande De Norte, 1982

Specialties

Pediatrics

Licenses

Pediatric Hematology-Oncology in WI

Board Certifications

Pediatrics (Sub: Pediatric Hematology/Oncology)

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Optima Health
  • HMO
  • POS
View 2 Less Insurance Carriers -

Locations

UC Davis Medical Center - Dept of Pediatrics
2516 Stockton Blvd, Ste 384, Sacramento, CA 95617

Additional Areas of Focus

Dr. Malogolowkin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


47 Clinical Trials

A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
View 46 Less Clinical Trials
Similar Doctors
Expertise in
9
conditions
Medical Genetics | Pediatrics
Expertise in
9
conditions
Medical Genetics | Pediatrics
2825 50th St Rm 2284, Uc Davis Mind Institute, 
Sacramento, CA 
 (0.3 miles away)
Languages Spoken:
English

Katherine Rauen is a Medical Genetics specialist and a Pediatrics provider in Sacramento, California. Dr. Rauen is highly rated in 9 conditions, according to our data. Her top areas of expertise are RASopathies, Costello Syndrome, Legius Syndrome, and Cardiofaciocutaneous Syndrome.

Expertise in
1
conditions
Pediatrics
Expertise in
1
conditions
Pediatrics

University Of California Medical Group

2825 50th St, 
Sacramento, CA 
 (0.7 miles away)
Languages Spoken:
English

Robin Hansen is a Pediatrics provider in Sacramento, California. Dr. Hansen is highly rated in 1 condition, according to our data. Her top area of expertise is Autism Spectrum Disorder.

Expertise in
12
conditions
Expertise in
12
conditions

Jonathan E. Kohler, MD Private Practice

2425 Stockton Blvd, 
Sacramento, CA 
 (0.1 miles away)
Languages Spoken:
English

Jonathan Kohler is a Pediatrics provider in Sacramento, California. Dr. Kohler is highly rated in 12 conditions, according to our data. His top areas of expertise are Umbilical Hernia, Omphalocele, Gastroschisis, Appendectomy, and Endoscopy.

Frequently Asked Questions about Dr. Marcio H. Malogolowkin

How do I make an appointment with Dr. Marcio H. Malogolowkin?

You can book an appointment with Dr. Marcio H. Malogolowkin by calling their office at 916-734-7098. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marcio H. Malogolowkin a top-rated expert for Hepatoblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marcio H. Malogolowkin is classified as an Elite expert for Hepatoblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marcio H. Malogolowkin specialize in?

While Dr. Marcio H. Malogolowkin is a Pediatrics, they have specific expertise in Hepatoblastoma, Germ Cell Tumor, and Adult Soft Tissue Sarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Marcio H. Malogolowkin participate in research or clinical trials?

Yes. Dr. Marcio H. Malogolowkin has published 86 articles and abstracts on conditions like Hepatoblastoma. You can view a list of Dr. Marcio H. Malogolowkin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marcio H. Malogolowkin accept my insurance?

Dr. Marcio H. Malogolowkin accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 916-734-7098 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Malogolowkin's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile